Cover Image

The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation

In clinical practice, reducing the burden of persistent atrial fibrillation by pharmacological means is challenging. We explored if blocking the background and the acetylcholine-activated inward rectifier potassium currents (IK1 and IKACh) could be antiarrhythmic in persistent atrial fibrillation. W...

Full description

Saved in:

Bibliographic Details
Main Authors:	Catalina Tobón (Author), Laura C. Palacio (Author), Bojjibabu Chidipi (Author), Diana P. Slough (Author), Thanh Tran (Author), Nhi Tran (Author), Michelle Reiser (Author), Yu-Shan Lin (Author), Bengt Herweg (Author), Dany Sayad (Author), Javier Saiz (Author), Sami Noujaim (Author)
Format:	Book
Published:	Frontiers Media S.A., 2019-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
by: Soo Min Jang, et al.
Published: (2020)

In vitro antimalarial activity evaluation of two ethnomedicinal plants against chloroquine sensitive and resistant strains of Plasmodium falciparum
by: Neelutpal Gogoi, et al.
Published: (2021)

Copper (I)-Chloroquine Complexes: Interactions with DNA and Ferriprotoporphyrin, Inhibition of β-Hematin Formation and Relation to Antimalarial Activity
by: Wilmer Villarreal, et al.
Published: (2022)

Atrial Fibrillation Mechanisms and Treatment
Published: (2013)

HYPERTHYROIDISM AND ATRIAL FIBRILLATION
by: I. M. Marusenko, et al.
Published: (2017)

Screening for atrial fibrillation
by: Zhenisgul Tlegenova, et al.
Published: (2018)

The Antimalarial Chloroquine Suppresses LPS-Induced NLRP3 Inflammasome Activation and Confers Protection against Murine Endotoxic Shock
by: Xiaoli Chen, et al.
Published: (2017)

Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022)

Atrial Fibrillation Basic Research and Clinical Applications
Published: (2012)

A single dose of in situ gel formulation of antimalarial drug chloroquine phosphate as a sustained prophylactic candidate for COVID-19
by: Noha Talal Zelai
Published: (2021)

Atrial Fibrillation Diagnosis and Management in the 21st Century
Published: (2022)

Stroke, Dementia and Atrial Fibrillation
Published: (2020)

Epidemiology and Treatment of Atrial Fibrillation
Published: (2020)

New Perspective in Atrial Fibrillation
Published: (2021)

Atrial Fibrillation Secondary to Dehydration
by: Kriti Bhatia
Published: (2014)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021)

Iron deficiency and atrial fibrillation
by: Metin Okşul, et al.
Published: (2018)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

Antimalarial mass drug administration in large populations and the evolution of drug resistance.
by: Tran Dang Nguyen, et al.
Published: (2023)

Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs
by: O. V. Gaisenok
Published: (2020)

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
by: Sijie Chang, et al.
Published: (2023)

Impact of Prolonged Cycle Length Resulting From Conversion of Atrial Fibrillation to Atrial Tachycardia on Ablation Outcome in Persistent Atrial Fibrillation Ablation
by: Jialing He, et al.
Published: (2024)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
by: Phil Mendys, et al.
Published: (2021)

The validity and reliability of Indonesian version of atrial fibrillation effect on quality of life (AFEQT) questionnaire for atrial fibrillation patients
by: Putri Zulmiyusrini, et al.
Published: (2023)

Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation
by: Mo P, et al.
Published: (2024)

Risk of atrial fibrillation in pemphigus vulgaris
by: Nastaran Namazi, et al.
Published: (2018)

Frailty and comorbidity burden in Atrial Fibrillation
by: Francesco Salis, et al.
Published: (2023)

Atrial fibrillation and the 4P medicine
by: Federica Censi, et al.
Published: (2013)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019)

Atrial fibrillation and the use of oral bisphosphonates
by: Michael Pazianas, et al.
Published: (2011)

Paroxysmal atrial fibrillation in cryptogenic stroke
by: Neha S Dangayach, et al.
Published: (2011)

Current Predictors of Atrial Fibrillation Progression
by: V. I. Podzolkov, et al.
Published: (2019)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016)

Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016)

CLINICAL AND GENETIC PECULIARITIES OF ATRIAL FIBRILLATION
by: S. Y. Nikulina, et al.
Published: (2016)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016)

Atrial Fibrillation Associated with Anticancer Drugs
by: O. D. Ostroumova, et al.
Published: (2020)

Experiences of living with symptomatic atrial fibrillation
by: Lena Holmlund, et al.
Published: (2023)